artemether has been researched along with Delayed Hypersensitivity in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, JY; He, PL; Li, Y; Sui, Y; Tang, W; Wang, JX; Wu, JM; Yang, ZS; Zhang, Y; Zhou, WL; Zhou, Y; Zuo, JP | 1 |
| Farsam, V; Hassan, ZM; Mahdavi, M; Noori, S; Ranjbar, M; Zavaran-Hosseini, A | 1 |
| Fu, YF; Li, Y; Ni, J; Shi, LP; Tang, W; Wan, J; Wang, JX; Yang, YF; Zhou, R; Zuo, JP | 1 |
3 other study(ies) available for artemether and Delayed Hypersensitivity
| Article | Year |
|---|---|
Synthesis and immunosuppressive activity of new artemisinin derivatives. 1. [12(beta or alpha)-Dihydroartemisininoxy]phen(ox)yl aliphatic acids and esters.
Topics: Animals; Antibody Formation; Artemisinins; B-Lymphocytes; Cell Proliferation; Concanavalin A; Dinitrofluorobenzene; Erythrocytes; Esters; Fatty Acids; Female; Hypersensitivity, Delayed; Immunosuppressive Agents; In Vitro Techniques; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; Mitogens; Sesquiterpenes; Sheep; Structure-Activity Relationship; T-Lymphocytes | 2005 |
Antitumor and immunomodulatory properties of artemether and its ability to reduce CD4+ CD25+ FoxP3+ T reg cells in vivo.
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents; Artemether; Artemisinins; CD4 Antigens; Dose-Response Relationship, Drug; Female; Forkhead Transcription Factors; Hypersensitivity, Delayed; Interleukin-2 Receptor alpha Subunit; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Spleen; T-Lymphocytes, Regulatory; Xenograft Model Antitumor Assays | 2011 |
Investigation of the immunosuppressive activity of artemether on T-cell activation and proliferation.
Topics: Animals; Artemether; Artemisinins; CD3 Complex; Cell Cycle; Cell Proliferation; Cell Survival; Concanavalin A; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Female; Hypersensitivity, Delayed; Immunity, Cellular; Immunologic Memory; Immunosuppressive Agents; Interferon-gamma; Interleukin-2; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mitogens; Ovalbumin; Phosphorylation; Proto-Oncogene Proteins c-raf; ras Proteins; T-Lymphocytes; Time Factors | 2007 |